These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

548 related items for PubMed ID: 12947061

  • 1. Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia.
    Den Boer ML, Harms DO, Pieters R, Kazemier KM, Gobel U, Körholz D, Graubner U, Haas RJ, Jorch N, Spaar HJ, Kaspers GJ, Kamps WA, Van der Does-Van den Berg A, Van Wering ER, Veerman AJ, Janka-Schaub GE.
    J Clin Oncol; 2003 Sep 01; 21(17):3262-8. PubMed ID: 12947061
    [Abstract] [Full Text] [Related]

  • 2. [In vitro drug resistance as independent prognostic factor in the study COALL-O5-92 Treatment of childhood acute lymphoblastic leukemia; two-tiered classification of treatments based on accepted risk criteria and drug sensitivity profiles in study COALL-06-97].
    Janka-Schaub GE, Harms DO, den Boer ML, Veerman AJ, Pieters R.
    Klin Padiatr; 1999 Sep 01; 211(4):233-8. PubMed ID: 10472556
    [Abstract] [Full Text] [Related]

  • 3. Biological characteristics and prognostic value of in vitro three-drug resistance to prednisolone, L-asparaginase, and vincristine in childhood acute lymphoblastic leukemia.
    Hongo T, Yamada S, Yajima S, Watanabe C, Fujii Y, Kawasaki H, Yazaki M, Hanada R, Horikoshi Y.
    Int J Hematol; 1999 Dec 01; 70(4):268-77. PubMed ID: 10643153
    [Abstract] [Full Text] [Related]

  • 4. Effectiveness of rubidomycin in induction therapy with vincristine, prednisone, and L-asparaginase for standard risk childhood acute lymphocytic leukemia: results of a Dutch phase III study (ALL V). A report on behalf of the Dutch Childhood Leukemia Study Group (DCLSG).
    van der Does-van den Berg A, van Wering ER, Suciu S, Solbu G, van 't Veer MB, Rammeloo JA, de Koning J, van Zanen GE.
    Am J Pediatr Hematol Oncol; 1989 Dec 01; 11(2):125-33. PubMed ID: 2665546
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Resistance to glucocorticoids in childhood acute lymphoblastic leukemia: impact of relationship between ex vivo sensitivity and in vivo concentration on risk factor analysis.
    Styczynski J, Koltan A, Wysocki M.
    Neoplasma; 2006 Dec 01; 53(2):168-73. PubMed ID: 16575474
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Fractionated cyclophosphamide added to the IVAP regimen (idarubicin-vincristine-L-asparaginase-prednisone) could lower the risk of primary refractory disease in T-lineage but not B-lineage acute lymphoblastic leukemia: first results from a phase II clinical study.
    Bassan R, Pogliani E, Lerede T, Fabris P, Rossi G, Morandi S, Casula P, Lambertenghi-Deliliers G, Vespignani M, Izzi T, Coser P, Corneo G, Barbui T.
    Haematologica; 1999 Dec 01; 84(12):1088-93. PubMed ID: 10586210
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Acute lymphoblastic leukemia in infants.
    Gürgey A, Yetgin S, Cetin M, Gümrük F, Tuncer AM, Tunçbilek E, Hiçsönmez G.
    Turk J Pediatr; 2004 Dec 01; 46(2):115-9. PubMed ID: 15214738
    [Abstract] [Full Text] [Related]

  • 15. [Long-term follow-up of 2 therapeutic programs for the treatment of high-risk childhood acute lymphoblastic leukemia. Experience at the 20 de Noviembre National Medical Center].
    de Diego-Floreschapa J, López-Hernández M, Borbolla-Escoboza JR, Trueba-Christy E, Carrillo-Rosales T, González-Avante M.
    Gac Med Mex; 1999 Dec 01; 135(3):253-8. PubMed ID: 10425822
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Treatment of children with acute lymphoblastic leukemia in India using a BFM protocol.
    Bajel A, George B, Mathews V, Viswabandya A, Kavitha ML, Srivastava A, Chandy M.
    Pediatr Blood Cancer; 2008 Nov 01; 51(5):621-5. PubMed ID: 18688848
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.